The HBA E.D.G.E. in Leadership Study is a benchmarking study that will focus on Empowerment, Diversity, Growth and Excellence in healthcare as it measured how well women have fared in the industry—and within their own organizations— relative to other companies and industries. The E.D.G.E. study was designed and executed to meet the significant need for dedicated research into the specialized life sciences industry. The study has delivered meaningful data and actionable insight for US and EU corporations and serves as a model for future progress in advancing women’s careers by providing critical benchmarks and best practices, similar to those already established for other Fortune 500 companies and industries such as technology, manufacturing, and consumer sales. Please see the details of the ground-breaking study on the E.D.G.E. webpage dedicated to the study findings.
The H.A.I.L. Survey
HBA Attributes & Influences of Leaders
In the spring of 2003 the Healthcare Businesswomen’s Association (HBA) and Pharmaceutical Executive conducted the H.A.I.L. survey on the attributes and influences of leaders in the healthcare industry. The results of that survey were first announced at the HBA’s Third Biennial Women’s Leadership Conference on June 5, 2003 and a summary was published in the August 2003 issue of Pharmaceutical Executive; “Integrity at the helm?” Shalo, S., Volume: 23 Number: 8 ISSN: 02796570 Publication Date: 08-01-2003 Page: S6.
It is with tremendous pleasure that we now offer you this link to a white paper, which reports in greater detail, what 898 industry professionals shared with us about the state of leadership in the U.S. economy, now and for the future.
The Power Study
Although women are represented in the industry in ever increasing numbers, they are still poorly represented in the leadership ranks and on senior-level operating committees. According to Catalyst, an organization that works with business and the professions to advance women across all industries, 11.2 percent of Fortune 500 corporate officers in 1998 were women—about 1,000 out of 11,000 positions. A survey of the 1998 annual reports of some 40 pharmaceutical companies reveals that fewer than 10 percent of senior managers are female, and 15 of the companies have no women at all in top positions. (See “How Many Women?”) Yet nearly half the labor force is female, as are more than half the current college students enrolled in undergraduate and master level programs, 40 percent of law school graduates, and a third of MBA graduates.
How Many Women
Recent studies have examined the progress, career advancement methods, and work-life balancing issues of the small population of women who have pierced the “glass ceiling” across many industries. Pharmaceutical companies’ own published reports reveal equally valuable information about the number of women in top management.